Clinical Research Directory
Browse clinical research sites, groups, and studies.
Switch of AndroidAPS to Commercially Available AID Systems
Sponsor: Charles University, Czech Republic
Summary
The aim of the study was to investigate the switch between open-source automated insulin delivery system (OS-AID) - AndroidAPS (AAPS) and commercially available AID systems - Control-IQ (CIQ) and MiniMed 780G (780G) in extended follow-up study.
Official title: Switch of Open-source Automated Insulin Delivery System - AndroidAPS to Commercially Available AID Systems in Type 1 Diabetes: the Extension of the CODIAC Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
41
Start Date
2020-12-01
Completion Date
2024-12-31
Last Updated
2024-11-29
Healthy Volunteers
No
Conditions
Interventions
Insulin pump with closed-loop system
Device: Usage of Insulin pump t:slim X2 with Control-IQ technology or MiniMed 780G with Smartguard technology in previous users of AndroidAPS
Locations (1)
3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University
Prague, Czech Republic, Czechia